Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.
Raptis, V., Loutradis C., & Sarafidis P. A. (2018).  Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts.. Nephrol Dial Transplant. 33(11), 1887-1895.
Papademetriou, V., Doumas M., Anyfanti P., Faselis C., Kokkinos P., & Tsioufis C. (2014).  Renal nerve ablation for hypertensive patients with chronic kidney disease.. Curr Vasc Pharmacol. 12(1), 47-54.
Papademetriou, V., Rashidi A. Adel, Tsioufis C., & Doumas M. (2014).  Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.. Circulation. 129(13), 1440-51.
Doumas, M., Lazaridis A., & Papademetriou V. (2014).  Renal nerve ablation for resistant hypertension: the dust has not yet settled.. J Clin Hypertens (Greenwich). 16(6), 399-400.
Kastritis, E., Gavriatopoulou M., Roussou M., Migkou M., Fotiou D., Ziogas D. C., et al. (2017).  Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.. Am J Hematol. 92(7), 632-639.
Prassopoulos, P., & Cavouras D. (1994).  Renal parenchymal thickness in children measured by computed tomography.. Eur Urol. 25(1), 51-4.
Musso, C., Liakopoulos V., Pangre N., DiTrolio J., Jauregui R., De Miguel R., et al. (2009).  Renal physiology in elderly persons with severe immobility syndrome.. Int Urol Nephrol. 41(2), 437-41.
Allegaert, K., Smits A., van Donge T., van den Anker J., Sarafidis K., Levtchenko E., et al. (2020).  Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions.. Front Pediatr. 8, 366.
Stavropoulos, K., Imprialos K. P., Athyros V. G., & Doumas M. (2018).  Renal resistive index for renovascular hypertension: In the quest of the Holy Grail.. J Clin Hypertens (Greenwich). 20(3), 589-591.
Doumas, M., Faselis C., & Papademetriou V. (2010).  Renal sympathetic denervation and systemic hypertension.. Am J Cardiol. 105(4), 570-6.
Doumas, M., Stavropoulos K., Imprialos K. P., Athyros V. G., & Karagiannis A. (2018).  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?. J Clin Hypertens (Greenwich). 20(4), 634-636.
Papademetriou, V., Doumas M., & Tsioufis K. (2011).  Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension.. Int J Hypertens. 2011, 196518.
Papademetriou, V., Doumas M., & Tsioufis C. (2016).  Renal Sympathetic Denervation: Hibernation or Resurrection?. Cardiology. 135(2), 87-97.
Doumas, M., Faselis C., & Papademetriou V. (2011).  Renal sympathetic denervation in hypertension.. Curr Opin Nephrol Hypertens. 20(6), 647-53.
Petidis, K., Anyfanti P., & Doumas M. (2011).  Renal sympathetic denervation: renal function concerns.. Hypertension. 58(4), e19; author reply e20.
Doumas, M., & Douma S. (2010).  Renal sympathetic denervation: the jury is still out.. Lancet. 376(9756), 1878-80.
Huerta, A., Bomback A. S., Liakopoulos V., Palanisamy A., M Stokes B., D'Agati V. D., et al. (2012).  Renal-limited 'lupus-like' nephritis.. Nephrol Dial Transplant. 27(6), 2337-42.
Sarafidis, P. A., & Bakris G. L. (2014).  Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?. J Renin Angiotensin Aldosterone Syst. 15(1), 97-8.
Georgianos, P. I., Sarafidis P. A., & Zebekakis P. E. (2014).  Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.. J Clin Hypertens (Greenwich). 16(7), 475-6.
Imprialos, K. P., Boutari C., Stavropoulos K., Sampani E., & Karagiannis A. I. (2016).  Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?. J Clin Hypertens (Greenwich). 18(8), 828.
Mediskou, P., Yavropoulou M. P., Kotsa K., Tsekmekidou X., Psarakou-Gotzamani A., Papazisi A., et al. (2011).  The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.. Clin Endocrinol (Oxf). 74(3), 306-11.
Sarafidis, P. A., & Ruilope L. M. (2013).  Renin-angiotensin-aldosterone system blockade in hypertensive patients with chronic kidney disease.. Blood Press. 22(6), 397-8.
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2019).  Renovascular Hypertension: Novel Insights:. Current Hypertension Reviews. 15,
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2020).  Renovascular Hypertension: Novel Insights.. Curr Hypertens Rev. 16(1), 24-29.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές